| WeekNo; |
Serum C-peptide |
Serum glucose (mg/dl) |
| GI#(n=12) |
GII##(n=12) |
GIII ٭(n=12) |
GIV ٭٭(n=12) |
GI(n=12) |
GII ٭ (n=12) |
GIII ٭ (n=12) |
GIV ٭٭(n=12) |
| Day 0 |
2.96 ± 0.36 |
3.05 ± 0.57 |
0.48 ± 0.21 |
0.24 ± 0.12 |
130 ± 5 |
133 ± 7 |
170 ± 8 |
350 ± 2 |
| Week 2 |
2.97 ± 049 |
3.11 ± 0.14 |
0.46 ± 0.32 |
0.17 ± 0.33 |
125 ± 5 |
129 ± 6 |
178 ± 9 |
350 ± 5 |
| Week 4 |
2.94 ± 0.23 |
3.02 ± 0.05 |
0.45 ± 0.27 |
0.14 ± 0.2 |
125 ± 8 |
123 ± 6 |
182 ± 9 |
368 ± 2 |
| Week 6 |
2.98 ± 0.11 |
3.03 ± 0.45 |
0.44 ± 0.13 |
0.14 ± 0.32 |
135 ± 4 |
121 ± 9 |
185 ± 4 |
410 ± 5 |
| Week 8 |
2.92 ± 0.42 |
3.03 ± 0.16 |
0.41 ± 0.18 |
0.12 ± 0.25 |
135 ± 3 |
133 ± 7 |
188 ± 4 |
429 ± 9 |
| Week 10 |
2.95 ± 0.21 |
3.02 ± 0.11 |
0.41 ± 0.13 |
0.09 ± 0.3 |
123 ± 8 |
129 ± 4 |
190 ± 5 |
450 ± 5 |
| Week 12 |
2.96 ± 0.11 |
3.04 ± 0.26 |
0.39 ± 0.34 |
0.08 ± 0.41 |
129 ± 3 |
123 ± 5 |
196 ± 4 |
490 ± 2 |
| Week 14 |
2.98 ± 0.25 |
3.14 ± 0.34 |
0.35 ± 0.11 |
0.08 ± 0.29 |
135 ± 2 |
121 ± 6 |
196 ± 9 |
490 ± 9 |
| Week 16 |
2.94 ± 0.37 |
3.02 ± 0.18 |
0.32 ± 0.15 |
0.06 ± 0.13 |
119 ± 9 |
125 ± 2 |
197 ± 8 |
500 ± 2 |
The values in each group are represented as Means ± Standard deviation. Significant p values (p<0.05) of both C-peptide and serum glucose were detected between (٭)
and (٭٭), however, insignificant p values (p>0.05) of C-peptide were displayed between (G1#) and (G2##). Group I (control or nondiabetic fed on ordinary lab diet); Group II
(non-diabetic fed on fatty diet); Group III (diabetic fed on ordinary lab diet); Group IV (diabetic fed on fatty diet); Day 0 = The first day after fat feeding following induction of
diabetes by injecting streptozotocin. Normal serum C-peptide was 0.5-3.0 ng/ml, serum glucose was 120-140 mg/dl. |
